About Turn Biotechnologies
Turn Biotechnologies is a private company based in Mountain View, California, incorporated in 2018 in Delaware. It has reported $29,132,219 raised in one offering on Form D since September 2023. Its chief executive is Anja Krammer.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 22, 2023 | Sep 6, 2023 | $29,132,219of $43.8M target | 55 | $529K | Equity, OptionsRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Turn Biotechnologies's Form D filed Sep 6, 2023.
VS
Vittorio Sebastiano
Director
MQ
Marco Quarta
Director
SC
Sergio Ruiz-Chinchilla
Executive officer
DG
David Gobel
Director
AK
Anja Krammer
Chief Executive Officer and director
RP
Ric Peterson
Executive officer